CRISPR Therapeutics CEO talks winning FDA approval for sickle cell anemia treatment

For improve playback, use the chrome extension Embedy High Definition for desktop and watch video at high speed with a resolution of 1080p
Samarth Kulkarni, CRISPR Therapeutics CEO, joins ’Closing Bell Overtime’ to talk winning FDA approval in the U.S. for sickle cell treatment in partnership with Vertex.
© 2025 - Embedy.ws » DMCA » Contact Us » Abuse » Tell a friend »
Back to Top